BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34048759)

  • 1. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
    Fabian T; Leung A
    Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
    Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
    Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
    J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
    Gopal DV; Lieberman DA; Magaret N; Fennerty MB; Sampliner RE; Garewal HS; Falk GW; Faigel DO
    Dig Dis Sci; 2003 Aug; 48(8):1537-41. PubMed ID: 12924649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of Barrett's esophagus.
    Milind R; Attwood SE
    World J Gastroenterol; 2012 Jul; 18(27):3483-91. PubMed ID: 22826612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
    Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
    Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus, dysplasia, and adenocarcinoma.
    Haggitt RC
    Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 18. Barrett's esophagus.
    Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
    J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence.
    Theisen J; Nigro JJ; DeMeester TR; Peters JH; Gastal OL; Hagen JA; Hashemi M; Bremner CG
    Dis Esophagus; 2004; 17(1):67-70. PubMed ID: 15209744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade dysplasia in Barrett's esophagus.
    Odze RD; Goldblum JR
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.